+
in $
+59.89%
Velo3D, Inc.
in NT$
+2.70%
Tong Yang Industry Co., Ltd.
1319.TW VLD-WT
Price 114.00 0.03
Movement +NT$ 3.00 +$ 0.01
Market Cap. 67.4 B 11.0 M
Volume 3.1 M 249,183
Volume μ 3.6 M 0
EPS TTM 6.57 0.00
P/E TTM 17.35 0.00
Dividend Yield TTM 4% -%
Shares Outstanding 591 M 395 M
Earnings Call March 6, 2025 March 31, 2023

Financial Comparison

Financial Statements
Click to show
VLD-WT
1319.TW
    • 2024
    • 2023
    • 2022
    • 2021
    • 2019
Profitability
Industry Average
Profit Margin
+188.21% YoY
-6.74
1.54
-1.75
Gross Margin
+110.55% YoY
-2.90
0.04
-0.34
Operating Margin
+24.97% YoY
-7.14
-1.29
-1.72
EBT Margin
+107.11% YoY
-6.78
0.12
-1.75
ETR
-% YoY
-
-
EPS
+198.53% YoY
-0.12
0.67
-0.68
EPS Dil.
+189.71% YoY
-0.14
0.61
-0.68
ROA
+162.84% YoY
-0.13
0.55
-0.88
ROE
+144.63% YoY
1.93
0.88
-1.98
ROIC
-575.59% YoY
-0.39
-8.68
-1.28
Takeaways
  • Negative 5Y revenue growth of --59.71% and +58.32% for the past 10 Years
  • The profit margin of -1.75 implies a positive signal, comparing the net margin against the industry avg. of -6.74
Market Prospects
P/E
+558.87% YoY
-292.49
93.28
-20.33
P/B
-104.79% YoY
102.69
82.33
40.20
P/TB
-104.79% YoY
102.69
82.33
40.20
Earnings Yield
+121.79% YoY
-0.34
0.01
-0.05
Other Metrics
EBITDA[in mil.]
+21.32% YoY
-
-97
-123
EBITDA Margin
+24.55% YoY
-6.58
-1.21
-1.60
WA[in mil.]
+6.22% YoY
-
185
197
WA Dil.[in mil.]
+6.22% YoY
-
185
197
Earnings & Forecasts
  • Hide e
    Reported
    Avg. Estimate
    Beat
    Miss
Next Earnings 1319.TW
Earnings Call Nov. 7, 2024
Avg. EPS Forecast 1.76
Potential Delta 0 %
Avg. Revenue Forecast 6,303 Mil.
Potential Delta - %
Dividends
Company Average
Tong Yang Industry Co., Ltd.
NT$4.00
Industry Average
Auto - Parts
NT$1.81

Investor Relations

Index
VLD-WT
Annual Statement April 3, 2024, midnight
Quarterly Statement May 15, 2024, midnight
Earnings Call n/a
Next Earnings Call tba
Shareholder Meeting n/a
Dividend n/a
FDA Filing n/a
Lobby Disclosure n/a
1319.TW
Annual Statement n/a
Quarterly Statement n/a
Earnings Call n/a
Next Earnings Call March 6, 2025
Shareholder Meeting n/a
FDA Filing n/a
Lobby Disclosure n/a

Strategic Comparison

Risks & Opportunities

Yet not available for any. Try a different selection.